The Saudi-led coalition in Yemen on Wednesday launched the "largest assault of Yemen's war," according to Reuters, for the port city of Hudaydah.

Expand chart
Data: IHS Markit Conflict Monitor; Map: Lazaro Gamio/Axios

The big picture: The battle puts hundreds of thousands of civilian lives at risk, UN humanitarian coordinator for Yemen Lise Grande told NPR. The port is a major lifeline for the Yemeni people, millions of whom are already suffering from famine, cholera, and other life-threatening conditions. Two-thirds of all humanitarian aid to Yemen enters through Hudaydah's port, per CNN, and 600,000 people living in the city and surrounding area are at risk from the conflict.

What's happening
  • The Emiratis are leading the charge, with the support of the Saudi-led coalition, in efforts to re-take Hudaydah from the Houthi rebels. Four Emirati casualties were confirmed on Wednesday, per the Washington Post.
  • Saudi Arabia and the UAE announced a plan to assist Hudaydah and its surrounding areas, Reuters reports. They plan to "distribute food, provide medical supplies, equipment and staff to hospitals, sustain electrical stations and provide economic support," while establishing shipping lanes from both countries to Hudaydah.
  • The UN Security Council met Thursday, per Reuters, to discuss the situation.
What they're saying
  • Perry Cammack, a former State Department official and a fellow at the Carnegie Empowerment for International Peace, told Axios that taking Hudaydah would be a major strategic win for the Saudis, as it would "cut off Hudaydah support to resupply the Houthis," and ultimately help them take the capital, Sana'a. However, he said, there are "potentially catastrophic humanitarian consequences."
  • David Miliband, President and CEO of the International Rescue Committee, said in a statement on Wednesday: "The attack on Hudaydah is an attack on the political and diplomatic process to bring peace to Yemen.  UN Security Council members including the U.S. and UK governments... must act now to secure a ceasefire before the people in Hudaydah city suffer the same fate as those in Aleppo, Mosul or Raqqa.”

Go deeper

Updated 13 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 6:30 p.m. ET: 20,177,521 — Total deaths: 738,716 — Total recoveries: 12,400,156Map.
  2. U.S.: Total confirmed cases as of 6:30 p.m. ET: 5,130,784 — Total deaths: 164,603 — Total recoveries: 1,670,755 — Total tests: 62,513,174Map.
  3. States: Georgia reports 137 coronavirus deaths, setting new daily record Florida reports another daily record for deaths.
  4. Health care: Trump administration buys 100 million doses of Moderna's coronavirus vaccine.
  5. Business: Moderna reveals it may not hold patent rights for vaccine.
  6. Sports: Big Ten scraps fall football season.

Voters cast ballots in Minnesota, Georgia, Connecticut, Wisconsin and Vermont

Photo: Spencer Platt/Getty Images

Primary elections are being held on Tuesday in Minnesota, Georgia, Connecticut, Vermont and Wisconsin.

The big picture: Georgia and Wisconsin both struggled to hold primaries during the coronavirus pandemic, but are doing so again — testing their voting systems ahead of the general election. Rep. Ilhan Omar (D-Minn.) is facing a strong challenger as she fights for her political career. In Georgia, a Republican primary runoff pits a QAnon supporter against a hardline conservative.

42 mins ago - Health

Trump administration buys 100 million doses of Moderna's vaccine

A volunteer in Moderna's vaccine clinical trial receives a shot. Photo: Paul Hennessy/NurPhoto via Getty Images

The U.S. government has agreed to buy 100 million doses of Moderna's experimental coronavirus vaccine for $1.5 billion, or $15 per dose.

Why it matters: The Trump administration, through Operation Warp Speed, has now bought initial batches of vaccines from Moderna, GlaxoSmithKline and Sanofi, Pfizer, Novavax, Johnson & Johnson and AstraZeneca before knowing whether they are safe and effective. The federal government also appears to own some of the patent rights associated with Moderna's vaccine.